Clearline Capital’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-436,437
Closed -$999K 135
2024
Q3
$999K Sell
436,437
-800
-0.2% -$2.44K 0.09% 116
2024
Q2
$1.28M Hold
437,237
0.11% 113
2024
Q1
$1.59M Sell
437,237
-57,269
-12% -$110K 0.16% 93
2023
Q4
$747K Hold
494,506
0.08% 85
2023
Q3
$663K Hold
494,506
0.07% 110
2023
Q2
$890K Hold
494,506
0.12% 90
2023
Q1
$821K Hold
494,506
0.12% 79
2022
Q4
$949K Hold
494,506
0.17% 87
2022
Q3
$1.11M Hold
494,506
0.15% 97
2022
Q2
$1.6M Hold
494,506
0.23% 77
2022
Q1
$2.6M Sell
494,506
-33,271
-6% -$187K 0.35% 74
2021
Q4
$4.27M Buy
527,777
+141,836
+37% +$1.3M 0.58% 54
2021
Q3
$3.84M Buy
385,941
+165,137
+75% +$1.5M 0.5% 61
2021
Q2
$2.06M Buy
220,804
+196,813
+820% +$2.24M 0.31% 69
2021
Q1
$251K Buy
+23,991
New +$268K 0.04% 107

Other funds holding NUVB